Industry
Drug Manufacturers - Specialty & Generic
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
Loading...
Open
0.26
Mkt cap
2.7M
Volume
396K
High
0.28
P/E Ratio
-0.07
52-wk high
2.27
Low
0.25
Div yield
N/A
52-wk low
0.22
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.